Regulation of Gonadotropin-Releasing Hormone (GnRH) Receptor-I Expression in the Pituitary and Ovary by a GnRH Agonist and Antagonist

Abstract

The aim of the current study was to examine the effects of gonadotropin-releasing hormone agonist (GnRH-a) and antagonist (GnRH-ant) on the expression of GnRH receptor-I (GnRHR-I) in pituitary and ovaries in cyclophosphamide (CTX) chemotherapeutic rats and to investigate the possible mechanism of interventions of GnRH-a and GnRH-ant in CTX-induced ovarian damage. In total, 36 female rats were distributed into 6 groups at random: normal saline (NS) group, CTX group, GnRH-a + NS group, GnRH-a + CTX group, GnRH-ant + NS group, and GnRH-ant + CTX group. After the rats were killed, the expression of GnRHR-I messenger RNAs (mRNAs) and proteins in pituitary and ovaries were examined by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot, respectively. The distribution of GnRHR-I in various compartments of the ovaries was observed by immunohistochemistry. Significant downregulation of GnRHR-I mRNA and protein expression in the pituitary were observed after treatment with GnRH-a or GnRH-ant. Moreover, GnRH-ant was more potent for this direct and fast inhibition. In ovary, GnRHR-I expression was significantly downregulated by GnRH-a. Although GnRH-ant slightly decreased the ovarian expression of GnRHR-I mRNA, the protein level was only weakly changed. In the ovarian compartment, GnRHR-ant groups had markedly GnRHR-I expression in early and late growing follicles compared to GnRHR-a groups that exhibited decreased expression of GnRHR-I, especially in late growing follicles. In summary, this study presents evidence for the different regulating effects of GnRH-a and GnRH-ant on the expression of GnRHR-I in pituitary and ovaries, which may provide insight into the mechanism of GnRH-a and GnRH-ant interventions on chemotoxic ovarian damage.

Keywords

GnRH analogue CTX GnRHR-I ovary pituitary.

Get full access to this article

View all access options for this article.

References

Peng P. , Yang DZ , Zheng CY , Mo YQ , He YM , Zhang QX Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats [in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2007;42(8):546-550.

Bines J. , Oleske DM , Cobleigh MA Ovarian function in pre-menopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729.

Goldhirsch A. , Gelber RD , Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol. 1990;1(3):183-188.

Moliterni A. , Bonadonna G. , Valagussa P. , Ferrari L. , Zambetti M. Cycolophosphamide, methotrexate and fluorouracil with and without doborubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes. J Chin Oncol . 1991;9(7):1124-1130.

Blumenfeld Z. , Avivi I. , Ritter M. , Rowe JM Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest. 1999;6(5):229-239.

Falcon T. , Bedaiwy MA Fertility preservation and pregnancy outcome after maglignancy. Curr Opin Obstet Gynecol. 2005; 17(1):21-26.

Ataya KM , McKanna JA , Weintraub AM , Clark MR , LeMaire WJ A luteinizing hormone-releasing hormone agonist for the preservation of chemotherapy-induced ovarian follicular loss in rats. Cancer Res. 1985;45(8):3651-3656.

Ortin TT , Shostak CA , Donaldson SS Gonadal status and reproductive function following treatment for Hodgkin’s disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys. 1990;19(4):873-880.

Wallace WH , Shalet SM , Tetlow LJ , Morris-Jones PH Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol. 1993; 21(5):333-339.

10.

Bokser L. , Szende B. , Schally AV Protective effects of D-Trp6-luteinizing hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats. Br J Cancer. 1990;61(6):861-865.

11.

Ataya K. , Ramahi-Ataya A. Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist. Reprod Toxicol. 1993;7(3):229-235.

12.

Fink G. Gonadotropin secretion and its control. In: Knobil E , Neill JD , et al, eds. The Physiology of Reproduction. New York: Raven; 1988:1349-1377.

13.

Halmos G. , Schally AV , Pinski J. , Vadillo-Buenfil M. , Groot K. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrrelix. Proc Natl Acad Sci U S A. 1996;93(6): 2398-2402.

14.

Halmos G. , Schally AV Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Proc Natl Acad Sci U S A. 2002 ;99(2):961-965.

15.

Kovacs M. , Schally AV , Csernus B. , Rekasi Z. Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH. Proc Natl Acad Sci U S A. 2001;98(4):1829-1834.

16.

Kovacs M. , Schally AV Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci U S A. 2001;98(21):12197-12202.

17.

Horvath JE , Bajo AM , Schally AV , Kovacs M. , Herbert F. , Groot K. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats. Proc Natl Acad Sci U S A. 2002;99(23):15048-15053.

18.

Murase M. , Uemura T. , Gao M. , Inada M. , Funabashi T. , Hirahara F. GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects. Endocr J . 2005;52(1):131-137.

19.

Leung PC , Cheng CK , Zhu XM Multi-factorial role of GnRH-I and GnRH-II in the human ovary. Mol Cell Endocrinol. 2003;202(1-2):145-153.

20.

Meirow D. , Assad G. , Dor J. , Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod. 2004;19(6):1294-1299.

21.

Danforth DR , Arbogasta LK , Friedman CI Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril. 2005;83(5):1333-1338.

22.

Hsueh AJ , Jones PB Extrapituitary actions of gonadotropin-releasing hormone. Endocr Rev. 1981;2(4):437-461.

23.

Janssens RM , Brus L. , Cahill DJ , Huirne JA , Schoemaker J. , Lambalk CB Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Hum Reprod Update. 2000; 6(5):505-518.

24.

Trimino E. , Pinilla L. , Aguilar E. Pituitary-gonadal function in neonatal and adult female rats treated with gonadotropin-releasing hormone agonist and antagonist: short- and long-term effects. Acta Endocrinol (Copenh). 1993 ;129(3):251-259.

25.

Kaiser UB , Zhao D. , Cardona GR , Chin WW Isolation and characterization of cDNAs encoding the rat pituitary GnRH receptor . Biochem Biophys Res Commun. 1992;189(3):1163-1169.

26.

Wong H. , Anderson WD , Cheng T. , Riabowol KT Monitoring mRNA expression by polymerase chain reaction: the ‘‘primer-dropping’’ method. Anal Biochem. 1994;223(2): 251-258.

27.

Westergaard CG , Byskov AG , Andersen CY Morphometric characteristics of the primordial to primary follicle transition in the human ovary in relation to age. Hum Reprod. 2007;22(8): 2225-2231.

28.

Felig Philip , Frohman Lawrence A. Endocrinology and Metabolism. 4th ed. New York, NY: McGraw-Hill; 2001.

29.

Norwitz ER , Cardona GR , Jeong KH , et al. Identification and characterization of the gonadotropin-releasing hormone receptor. Mol Cell Endocrinol. 1992 ;6:1163-1169.

30.

Bussenot I. , Azoulay Barjonet C. , Parinoud J. Modulation of the steroido-genesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs. J Cin Endocrinol Metab. 1993 ;76(5):1376-1379.

31.

Roth C. , Leonhardt S. , Seidel C. , Luft H. , Wuttke W. , Jarry H. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonist and the GnRH antagonist cetrocelix using a female rat model. Pediatr Res. 2000;48(4): 468-474.

32.

Roth C. , Schricker M. , Lakomek M. , et al. Autoregulation of the gonadotropin-releasiong hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J endocrinol. 2001;169(2):361-405.

33.

Bauer-Dantoin AC , Jameson JL Gonadotropin-releasing hormone receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle. Endocrinology. 1995; 136(10):4432-4438.

34.

Whitelaw PF , Eidne KA , Sellar R. , Smyth CD , Hillier SG Gonadotropin-releasing hormone receptor messenger ribonucleic acid expression in rat ovary. Endocrinology. 1995;136(1): 172-179.

35.

Hsueh AJ , Jones PB Extrapituitary actions of gonadotropin-releasing hormone. Endocr Rev. 1981;2(4):437-461.

36.

Takekida S. , Deguchi J. , Samoto T. , et al. Comparative analysis of the effects of gonadotropin-releasing hormone agonist on the proliferative activity, apoptosis, and steroidogenesis in cultured porcine granulosa cell at varying stages of follicular growth. Endocrine. 2000 Feb;12(1):61-7.

37.

Takekida S. , Matsuo H. , Maruo T. GnRH agonist action on granulosa cells at varying follicular stages. Mol Cell Endocrinol. 2003;202(1-2):155-164.

38.

Hillensjo T. , LeMaire WJ Gonadotropin-releasing hormone agonist stimulate meiotic maturation of follicle-enclosed rat oocytes in vitro. Nature. 1980;287(5778):145-146.

39.

Parinaud J. , Beaur A. , Bourreau E. , Vieitez G. , Pontonnier G. Effects of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril. 1988;50(4):597-602.

40.

Nathwani PS , Kang SK , Cheng KW , Choi KC , Leung PC Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17beta-estradiol in cultured human granulosa-luteal cells. Endocrinology. 2000;141(5): 1754-1763.

41.

Väänänen JE , Tong BL , Väänänen CM , Chan IH , Yuen BH , Leung PC Interaction of prostaglandin F2 alpha and gonadotropin-releasing hormone on progesterone and estradiol production in human granulosa-luteal cells. Biol Reprod. 1997;57(6):1346-1353.

42.

Irusta G. , Parborell F. , Peluffo M. , et al. Steroidogenetic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist. Biol Reprod. 2003;68(5):1577-1583.